-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
LENZ Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2020 to Q3 2025.
- LENZ Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$16.7M, a 63.5% decline year-over-year.
- LENZ Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$58.9M, a 3.17% increase year-over-year.
- LENZ Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$49.8M, a 28.9% increase from 2023.
- LENZ Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$70M, a 30.8% increase from 2022.
- LENZ Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$101M, a 42.8% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)